PharmaVoice

JUNE 13, 2023

Collaboration is important along the entire spectrum and lifecycle of biopharma, and finding an effective partner is harder than it sounds.

265

265

Pharmaceutical Technology

JUNE 12, 2023

On 9 May, National Fentanyl Awareness Day was observed in recognition of the US opioid crisis. Accordingly, the development of non-opioid painkillers is experiencing a surge in activity and despite numerous novel targets receiving high levels of attention, cannabinoids have emerged as strong favourites to replace opioid-related medications. The North American opioid epidemic highlights limitations in opioid use, such as the potential for drug abuse and overdose.

Immunity 143

Immunity Immunization Drug Development 143

Pharmaceutical Technology

JUNE 13, 2023

The US Food and Drug Administration (FDA) has accepted AstraZeneca’s new drug application (NDA) for the combination of capivasertib and FASLODEX (fulvestrant), and granted it priority review. The combination therapy is intended to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer in adult patients, after recurrence or progression on or after an endocrine-based regimen.

98

98

cureatr

JUNE 15, 2023

When it comes time for a patient to choose their healthcare provider, it's important for them to understand who they're choosing to help ensure they are getting the best care possible. One sure way for the patient to know what to expect from their provider is by reviewing rankings and ratings around quality measures before deciding.

Hospitals 86

Hospitals 86

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

JUNE 12, 2023

The treatment candidate, known as MDI-26478, is a positive allosteric modulator of the AMPA receptor - News - PharmaTimes

121

121

Pharma Times

JUNE 15, 2023

Researchers show silver retains antimicrobial activity for longer when it is infused into bioactive glass - News - PharmaTimes

102

102

STAT

JUNE 14, 2023

Endometriosis, a common gynecological condition, is one of health’s great mimickers. It can manifest as a variety of painful symptoms but evade detection on scans and examinations. And for the estimated 10% to 15% of women with endometriosis, it can take over a decade to get a diagnosis. Part of the lag is because researchers still don’t know exactly how endometriosis occurs, except that the flow of menstrual blood backward through the fallopian tubes plays a role in some cases.

280

280

PharmaVoice

JUNE 16, 2023

Industry execs give voice to the “game changers” they believe would have the greatest impact on the healthcare ecosystem for all.

246

246

Pharma Times

JUNE 13, 2023

525-patient trial intends to assess ‘complement activation’ during HD in patients with end stage renal failure - News - PharmaTimes

118

118

BioPharma Dive

JUNE 14, 2023

The FDA last year turned back an approval request from the drug’s former developer, Levo Therapeutics. That biotech is now owned by Acadia, which will run a new study designed to boost its odds of success.

112

112

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

STAT

JUNE 13, 2023

Police drug busts are strongly associated with a large and sudden spike in overdose deaths, according to a new study. In the week following a major opioid bust, fatal overdoses in the same neighborhood in Indianapolis doubled, the analysis showed. Calls to 911 and the use of naloxone , the overdose-reversal medication, also spiked.

363

363

PharmaVoice

JUNE 12, 2023

Tris Pharma’s CEO is “betting the company” on a pain reliever with the power of an opioid and a lower chance of addiction.

246

246

The Thyroid Pharmacist

JUNE 16, 2023

Over the past few years, my mission to help people recover from Hashimoto’s has become increasingly focused on using food as medicine (or food pharmacology) to address many of the root causes and symptoms of thyroid conditions. In addition to incorporating healing foods into my diet, I’ve also discovered many herbs and spices that can have profound benefits for healing.

Diabetes 107

Diabetes Dosage Compounding Immunity 107

BioPharma Dive

JUNE 15, 2023

Lilly will pay the genetic medicine specialist $60 million upfront to work together on a treatment targeting a risk factor known as Lp(a).

124

124

STAT

JUNE 13, 2023

CHICAGO — The American Medical Association on Tuesday strongly criticized the body mass index , urging doctors to de-emphasize its use in assessing health and obesity and acknowledging that the measurement has been used for “racist exclusion” and has caused “historical harm.” The AMA, one of the largest medical groups in the U.S., voted to adopt this policy during its annual meeting here.

346

346

The Pharmacist

JUNE 15, 2023

Health secretary Steve Barclay outlined his commitment to investing in technology, preventing ill health, and supporting innovation such as personalised medicines in a speech at the NHS Confed Expo today. This comes as the NHS mandate, which sets out the government’s asks of the NHS, was published today. It outlined three key priorities: cutting waiting […] The post Health secretary commits to tech, genomics and prevention agenda appeared first on The Pharmacist.

98

98

PhRMA

JUNE 14, 2023

The 340B Drug Pricing Program has grown yet again , exceeding $100 billion in sales in 2022 when 340B-priced medicines are measured at wholesale acquisition cost. Recent data from IQVIA shows 340B grew 12.2% year-over-year in 2022, continuing a trend in which 340B sales have almost doubled since 2018, outpacing growth of the total U.S. drug market.

Drug Pricing 104

Drug Pricing 104

BioPharma Dive

JUNE 12, 2023

Decentralized clinical trials (DCTs) bring many benefits to the clinical research process, and more importantly, the patients. However, it is important to remember the risks if there is no data security process in place.

106

106

STAT

JUNE 13, 2023

Adolescents who seek treatment for opioid addiction at an inpatient facility are more likely to be offered horseback riding than given full access to a common, highly effective addiction medication. According to a new research paper, just one out of every eight residential treatment facilities open to patients ages 16 or 17 offers full access to buprenorphine.

Inpatient 337

Inpatient 337

Pharma Times

JUNE 14, 2023

Find out more about the PharmaTimes Communications Awards 2023 – key dates, categories and which charity we have partnered with this year!

Communication 108

Communication 108

Express Pharma

JUNE 16, 2023

In this video: Dr Sanjay Kumar Jain, President – India Operations, Amneal Pharmaceuticals Topic: Enabling and optimising operational excellence Key Takeaway: Performance management, leadership, people, culture, continous improvement, risk and quality management etc are some of the key enablers of operational excellence. The post Dr Sanjay Kumar Jain, President – India Operations, Amneal Pharmaceuticals appeared first on Express Pharma.

98

98

Putting Patients First Blog

JUNE 15, 2023

Guest Blog: Understanding Myasthenia Gravis, a Rare Neuromuscular Disease June 15, 2023 By Samantha Masterson, President and CEO, Myasthenia Gravis Foundation of America When graduate student Audrey Getman first experienced myasthenia gravis symptoms, she thought she was having a stroke. “It came on gradually – I started noticing some facial weakness and then I couldn’t use my mouth,” she says.

Immunity 98

Immunity Immunization 98

STAT

JUNE 12, 2023

Brain responses to nutrients in the gut are impaired in people with obesity, and that doesn’t change even after they lose weight through changes in diet, a new study finds, adding to mounting research showing the complexity and persistence of the biological effects of obesity. Using brain imaging, researchers saw that when people without obesity received nutrients, they experienced reduced activity in areas of the brain involved in food intake, suggesting the brain is signaling to them th

312

312

Pharma Times

JUNE 16, 2023

Company will gain access to a considerable pipeline of liquid products covering various disease areas - News - PharmaTimes

115

115

Pharmaceutical Technology

JUNE 15, 2023

Eloxx has revealed its lead candidate ELX-02 improved predicted forced expiratory volume (ppFEV1) in patients with Class 1 cystic fibrosis (CF) in a new analysis of a Phase II trial that missed its efficacy endpoints. Following underwhelming topline results from the Phase II trial (NCT04135495) announced in late 2022, Eloxx recalculated the results using the change in ppFEV1 (a secondary outcome) from day 1 instead of from baseline.

98

98

Pharmaceutical Commerce

JUNE 14, 2023

In this latest Harvard Business School Healthcare Alumni Association Q&A, Susan Wilner Golden, DSC, lecturer at the Stanford Graduate School of Business, reveals an untapped $22 trillion global opportunity for all companies and others supporting healthy aging and longer life spans.

98

98

STAT

JUNE 13, 2023

This article was co-published with The Markup , a nonprofit newsroom that investigates how powerful institutions are using technology to change our society. Sign up for its newsletters here. Websites for mental health crisis resources across the country — which promise anonymity for visitors, many of whom are at a desperate moment in their lives — have been quietly sending sensitive visitor data to Facebook, The Markup has found.

306

306

The Pharmacist

JUNE 14, 2023

The Royal Pharmaceutical Society (RPS) and the Royal College of GPs (RCGP) have been commissioned by NHS England to develop tools and guidance for use in primary care to improve repeat prescribing. The toolkit will aim to reduce overprescribing by improving the consistency of repeat prescribing processes and by providing training resources for clinicians.

94

94

Putting Patients First Blog

JUNE 13, 2023

PRIDE: The uprising for equitable LGBTQ+ rights June 13, 2023 By: Omar A. Escontrías, DrPH, MPH, Senior Vice President of Equity, Research and Programs The LGBTQ+ community faces unique health care needs, and access to mental health treatment without stigma is among the most pressing. -Admiral Dr. Rachel L. Levine 17 th Assistant Secretary for Health United States, Department of Health and Human Services As I walk through DuPont and Logan Circles, two Lesbian, Gay, Bisexual, Transgender, Queer/Q

Immunity 98

Immunity Immunization 98

Pharmaceutical Technology

JUNE 13, 2023

Beacon Therapeutics has kickstarted its entry into the gene therapy field with a $120m Series A financing. The British investment trust Syncona Limited launched the new ophthalmic gene therapy company by combining Applied Genetic Technologies Corporation’s (AGTC’s) late-stage X-linked retinitis pigmentosa (XLRP) programme with two proprietary preclinical programmes.

98

98

STAT

JUNE 16, 2023

Over the past several months, my conversations with colleagues in the Alzheimer’s field have featured an unusual sentiment: optimism inflected with worry. Optimism because, after years of failed studies and the disastrous accelerated approval of aducanumab, we’re enjoying a less than one-year-old streak of good news. The latest bright flash is the June 9 Food and Drug Administration hearing on the anti-amyloid antibody lecanemab (to be sold by Eisai as Leqembi).

Drug Pricing 288

Drug Pricing 288

The Pharmacist

JUNE 15, 2023

Managing the sale of e-cigarettes through community pharmacies could have prevented soaring levels of vaping among children, shadow health secretary Wes Streeting has suggested. In response to an audience question at NHS Confed Expo yesterday afternoon, Mr Streeting said that there a role for community pharmacies to play a bigger part in preventing ill health […] The post Pharmacies could have played key role in anti-vaping, shadow health secretary suggests appeared first on The Pharmacist

Community Pharmacies 91

Community Pharmacies 91

BioPharma Dive

JUNE 12, 2023

DeSouza is departing unrepentant about his decision to close the Grail deal, telling colleagues his belief in the merger “remains unshakeable.

109

109

Pharmaceutical Technology

JUNE 14, 2023

The US Food and Drug Administration (FDA) has granted fast track designation for CellCentric’s inobrodib (CCS1477) to treat relapsed or refractory multiple myeloma patients. Inobrodib is an oral first-in-class cancer drug, indicated for patients who have previously received four or more lines of therapy, including an anti-CD38 monoclonal antibody, an immunomodulatory agent and a proteasome inhibitor.

97

97

STAT

JUNE 11, 2023

The sudden resignation of Francis deSouza as the CEO of Illumina Sunday represents anything but an orderly transition — and it leaves a black mark on both his six-year tenure and his luckless quest to acquire the cancer diagnostics firm Grail. But when the story of deSouza’s time as CEO is taught in management classes, it may be that the discussion should not just be about the decisions he made at the end.

275

275